Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Operating through its various subsidiaries, Red Eye Guys Ltd. specializes in creating and manufacturing the Biologix Hair Therapy System. This innovative system includes both a specialized formulation and an administration method to combat Follicle Nutrient Deficiency Syndrome (FNDS). A key element of this system is Biologix Revive, a particular hair formula that is delivered directly to FNDS-compromised follicles via a series of precise, shallow needle injections. The company's therapeutic solution is engineered to address, reverse the effects of, and prevent the onset of FNDS, as well as to treat alopecia areata. Known as Biologix Hair, Inc. until April 2014, the firm subsequently changed its name to Red Eye Guys Ltd. The company is headquartered in Toronto, Canada, and maintains subsidiary operations in Barbados and Panama.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.